research
-
A scientist’s opinion : Interview with Prof. Anna Odone about COVID-19 & GDPR
We speak with Anna Odone, Associate Professor of Public Health at the Faculty of Medicine of the University Vita-Salute San Raffaele in Milan. As a consultant physician, responsible for the Unit of Clinical Epidemiology and Health Technology Assessment at San Raffaele Scientific Institute, she is the... -
A scientist’s opinion : Interview with Professor Giovanni Rezza on tackling the Covid-19 pandemic
Tackling the Covid-19 pandemic, a scientist’s opinion We speak with Professor Giovanni Rezza, MD, Director of the Department of Infectious Diseases at the Istituto Superiore di Sanità, Roma, Italy about the EU’s announcement of funding for research to tackle Covid-19, and current efforts to develop... -
A scientist’s opinion : Interview with Professor Paul Digard on research efforts to develop treatments against Covid-19
Research efforts to develop treatments against Covid-19 Professor Paul Digard, virologist at The Roslin Institute, University of Edinburgh, tells us about potential routes to Covid-19 treatment and the prospect of having to deal with the virus long-term. How soon do you think a vaccine against... -
A scientist’s opinion : Interview with Aroon Hingorani about re-engineering pharmaceutical research
Interview with Aroon Hingorani, Professor of Genetic Epidemiology at University College London about Re-engineering pharmaceutical research. Could you speculate what you think are the biggest causes of drug failure? Aroon Hingorani: It is well recognised that the number one cause for drug failure... -
A scientist’s opinion : Interview with Dr Denis Lacombe about re-engineering pharmaceutical research
Interview with Dr Denis Lacombe, Director General of the European Organisation for Research and Treatment of Cancer (EORTC) about Re-engineering pharmaceutical research. Can you tell me a bit about the European Organisation for Research and Treatment of Cancer (EORTC)? Denis Lacombe: We are a non-governmental,... -
Re-engineering pharmaceutical research for better patient outcomes
A so-called ‘productivity crisis’ has been ascribed to the pharmaceutical research and development industry. Despite increases in investment and funding, this has not corresponded to increases in the approval of novel drugs. Why do so many drugs fail to receive approval, and what other means should we...
-
A scientist’s opinion : Interview with Dr Síle Lane about re-engineering pharmaceutical research
Interview with Dr Síle Lane, head of international campaigns and policy at Sense About Science, about Re-engineering pharmaceutical research. Undisclosed clinical trial results are unfortunately common - how does this impact progression in research and treatment? Síle Lane: When results from clinical... -
SOMA consortium scales up anti-disinformation efforts across EU Member States
Horizon-2020-supported Social Observatory for Disinformation and Social Media Analysis links academic, technological and media expertise to combat disinformation (SOMA).